Award

CA152990

Funder: Cancer Research UK

Funded outputs count: 5

Funder award ID: CA152990

OpenAlex ID: G5751515744

Estimating the ovarian cancer CA-125 preclinical detectable phase, in-vivo tumour doubling time, and window for detection in early stage: an exploratory analysis of UKCTOCS

2025 · Jacob S. Bedia, Ian J. Jacobs, et al. · EBioMedicine · 15

Development of a longitudinal two-biomarker algorithm for early detection of ovarian cancer in women with BRCA mutations

2020 · Scott E. Lentz, C. Bethan Powell, et al. · Gynecologic Oncology · 4

Multi-Marker Longitudinal Algorithms Incorporating HE4 and CA125 in Ovarian Cancer Screening of Postmenopausal Women

2020 · Aleksandra Gentry-Maharaj, Oleg Blyuss, et al. · Cancers · 33

The cost-effectiveness of screening for ovarian cancer: results from the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)

2017 · Usha Menon, Alistair J McGuire, et al. · British Journal of Cancer · 36

The sex hormone system in carriers of BRCA1/2 mutations: a case-control study

2013 · Martin Widschwendter, Adam N Rosenthal, et al. · The Lancet Oncology · 122